Netarsudil News
Netarsudil currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Netarsudil with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Reduction of elevated intraocular pressure (IOP) in adult patients with primary open-angle glaucoma or ocular hypertension.
- Evidence level: L5
- Predicted indications (20):
- open-angle glaucoma (99.6%)
- primary hereditary glaucoma (99.5%)
- glaucoma (99.5%)
- hypoglycemia (98.7%)
- Axenfeld anomaly (98.6%)
- glaucoma 1, open angle (98.5%)
- open angle glaucoma (98.1%)
- hydrophthalmos (97.5%)
- hereditary thrombocytopenia with normal platelets (97.5%)
- dense granule disease (97.5%)
- marcothrombocytopenia with mitral valve insufficiency (97.5%)
- transient neonatal thrombocytopenia (97.3%)
- lingual-facial-buccal dyskinesia (97.2%)
- thrombocytopenia (97.0%)
- visceral calciphylaxis (97.0%)
- chronic tic disorder (96.9%)
- benign shuddering attacks (96.9%)
- extrapyramidal and movement disease (96.9%)
- psychogenic movement disorders (96.5%)
- benign paroxysmal tonic upgaze of childhood with ataxia (96.5%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.